Peter L. Toogood
Medicinal Chemistry
Cancer Pharmacology
and Pharmacokinetics
Dynamics and Metabolism
USA
Name/email consistency: high
- Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. Toogood, P.L., Harvey, P.J., Repine, J.T., Sheehan, D.J., VanderWel, S.N., Zhou, H., Keller, P.R., McNamara, D.J., Sherry, D., Zhu, T., Brodfuehrer, J., Choi, C., Barvian, M.R., Fry, D.W. J. Med. Chem. (2005)
- Inhibition of protein-protein association by small molecules: approaches and progress. Toogood, P.L. J. Med. Chem. (2002)
- Progress toward the development of agents to modulate the cell cycle. Toogood, P.L. Curr. Opin. Chem. Biol (2002)
- Cyclin-dependent kinase inhibitors for treating cancer. Toogood, P.L. Med. Res. Rev (2001)









